US authorizes first home test for three common sexually transmitted infections
- The U.S. Food and Drug Administration has approved the first-ever at-home test kit for chlamydia, gonorrhea, and trichomoniasis, which can be used without a prescription.
- The Visby Medical Women's Sexual Health Test accurately identifies chlamydia, gonorrhea, and trichomoniasis and shows results on a connected app in about 30 minutes.
- Courtney Lias from the FDA stated that expanding access to at-home STI testing is crucial for diagnosing and treating infections.
- In 2023, there were over 1.6 million reported cases of chlamydia and 601,319 cases of gonorrhea in the U.S., highlighting the importance of accessible testing.
81 Articles
81 Articles
Counties with the highest STI rates in California
Canva Counties with the highest STI rates in California Sexually transmitted infections are on the rise, putting more people at risk as they spread. Chlamydia rates have nearly doubled since 2000, while the rate of gonorrhea went up by 50% over the same period. The Centers for Disease Control and Prevention reports that syphilis rates are reaching levels last seen in the 1950s. But some regions of the U.S. are seeing higher rates than others. St…

FDA Approves First At-Home Test to Diagnose Three STIs in Women
TUESDAY, April 1, 2025 (HealthDay News) -- The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women, the agency announced Friday.
At-home cervical screening: Scientists advise on self-sampling tests
At-home self-sampling cervical screening looks likely to be an option in the future. But scientists warn that steps must be taken to ensure that the offer of at-home sampling doesn't have a negative impact on cervical screening rates and that they are used by underserved and at-risk groups.
Coverage Details
Bias Distribution
- 61% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage